HEADER VIRAL PROTEIN 18-JUN-22 8DDK TITLE CCHFV GP38 HOTI/KOSOVO BOUND WITH CC5_17 CAVEAT 8DDK RESIDUES GLN B 153 AND SER B 154 THAT ARE NEXT TO EACH OTHER CAVEAT 2 8DDK IN THE SAMPLE SEQUENCE ARE NOT PROPERLY LINKE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAVY CHAIN CC5-17; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: LIGHT CHAIN CC5_17; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: ENVELOPMENT POLYPROTEIN; COMPND 11 CHAIN: C; COMPND 12 SYNONYM: M POLYPROTEIN; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 11 MOL_ID: 3; SOURCE 12 ORGANISM_SCIENTIFIC: CRIMEAN-CONGO HEMORRHAGIC FEVER SOURCE 13 ORTHONAIROVIRUS; SOURCE 14 ORGANISM_TAXID: 1980519; SOURCE 15 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS CRIMEAN-CONGO HEMORRHAGIC FEVER, CCHFV, GLYCOPROTEIN, GP38, HOTI, KEYWDS 2 KOSOVO, 13G8, FAB, VIRAL PROTEIN, CC5-17, MAB EXPDTA X-RAY DIFFRACTION AUTHOR I.A.DURIE,E.BERGERON,S.D.PEGAN,J.MCGUIRE REVDAT 2 25-OCT-23 8DDK 1 REMARK REVDAT 1 14-DEC-22 8DDK 0 JRNL AUTH I.A.DURIE,Z.R.TEHRANI,E.KARAASLAN,T.E.SORVILLO,J.MCGUIRE, JRNL AUTH 2 J.W.GOLDEN,S.R.WELCH,M.H.KAINULAINEN,J.R.HARMON,J.J.MOUSA, JRNL AUTH 3 D.GONZALEZ,S.ENOS,I.KOKSAL,G.YILMAZ,H.N.KARAKOC,S.HAMIDI, JRNL AUTH 4 C.ALBAY,J.R.SPENGLER,C.F.SPIROPOULOU,A.R.GARRISON, JRNL AUTH 5 M.M.SAJADI,E.BERGERON,S.D.PEGAN JRNL TITL STRUCTURAL CHARACTERIZATION OF PROTECTIVE NON-NEUTRALIZING JRNL TITL 2 ANTIBODIES TARGETING CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS. JRNL REF NAT COMMUN V. 13 7298 2022 JRNL REFN ESSN 2041-1723 JRNL PMID 36435827 JRNL DOI 10.1038/S41467-022-34923-0 REMARK 2 REMARK 2 RESOLUTION. 3.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.07 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 13699 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.305 REMARK 3 R VALUE (WORKING SET) : 0.304 REMARK 3 FREE R VALUE : 0.335 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 644 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.0700 - 6.5900 0.97 2731 147 0.2898 0.3095 REMARK 3 2 6.5900 - 5.2400 0.99 2662 133 0.3423 0.3989 REMARK 3 3 5.2400 - 4.5700 0.98 2600 136 0.2904 0.3396 REMARK 3 4 4.5700 - 4.1600 0.98 2576 126 0.3085 0.3338 REMARK 3 5 4.1600 - 3.8600 0.95 2486 102 0.3288 0.3645 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.450 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 42.540 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 247.1 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 20.1997 -55.4393 0.1314 REMARK 3 T TENSOR REMARK 3 T11: 1.9444 T22: 1.6519 REMARK 3 T33: 1.1331 T12: -0.2127 REMARK 3 T13: -0.2901 T23: 0.0634 REMARK 3 L TENSOR REMARK 3 L11: 2.3462 L22: 8.8704 REMARK 3 L33: 1.4449 L12: 3.5355 REMARK 3 L13: 0.1527 L23: 1.8277 REMARK 3 S TENSOR REMARK 3 S11: -0.2590 S12: -0.0454 S13: 0.4813 REMARK 3 S21: -1.0930 S22: 0.1130 S23: -0.3725 REMARK 3 S31: -1.0100 S32: 0.4476 S33: 0.1338 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8DDK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1000266457. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-DEC-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13942 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.850 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 7.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.92 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 8DC5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 72.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG1000, AND 0.1M HEPES PH 6.4, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 46.07900 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 87.83800 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 87.83800 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 69.11850 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 87.83800 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 87.83800 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 23.03950 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 87.83800 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 87.83800 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 69.11850 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 87.83800 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 87.83800 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 23.03950 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 46.07900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 42 REMARK 465 LYS A 43 REMARK 465 GLY A 44 REMARK 465 GLY A 66 REMARK 465 GLY A 101 REMARK 465 GLY A 102 REMARK 465 SER A 103 REMARK 465 SER A 104 REMARK 465 PHE A 105 REMARK 465 GLY A 106 REMARK 465 ASN A 107 REMARK 465 TYR A 119 REMARK 465 SER A 137 REMARK 465 VAL A 138 REMARK 465 PHE A 139 REMARK 465 PRO A 140 REMARK 465 LEU A 141 REMARK 465 ALA A 142 REMARK 465 PRO A 143 REMARK 465 SER A 144 REMARK 465 SER A 145 REMARK 465 LYS A 146 REMARK 465 SER A 147 REMARK 465 THR A 148 REMARK 465 SER A 149 REMARK 465 GLY A 150 REMARK 465 GLY A 151 REMARK 465 THR A 152 REMARK 465 ALA A 153 REMARK 465 ALA A 154 REMARK 465 LEU A 155 REMARK 465 GLY A 156 REMARK 465 CYS A 157 REMARK 465 LEU A 158 REMARK 465 VAL A 159 REMARK 465 SER A 196 REMARK 465 SER A 197 REMARK 465 VAL A 201 REMARK 465 LYS A 227 REMARK 465 VAL A 228 REMARK 465 GLU A 229 REMARK 465 PRO A 230 REMARK 465 LYS A 231 REMARK 465 SER A 232 REMARK 465 CYS A 233 REMARK 465 GLY A 234 REMARK 465 SER A 235 REMARK 465 HIS A 236 REMARK 465 HIS A 237 REMARK 465 HIS A 238 REMARK 465 HIS A 239 REMARK 465 HIS A 240 REMARK 465 HIS A 241 REMARK 465 HIS A 242 REMARK 465 HIS A 243 REMARK 465 ASP B 1 REMARK 465 SER B 10 REMARK 465 LEU B 11 REMARK 465 SER B 12 REMARK 465 ALA B 13 REMARK 465 GLN B 37 REMARK 465 GLN B 38 REMARK 465 LYS B 39 REMARK 465 PRO B 40 REMARK 465 GLY B 41 REMARK 465 LYS B 42 REMARK 465 ALA B 43 REMARK 465 PRO B 44 REMARK 465 LYS B 45 REMARK 465 SER B 76 REMARK 465 SER B 77 REMARK 465 LEU B 78 REMARK 465 GLN B 79 REMARK 465 PRO B 80 REMARK 465 GLU B 81 REMARK 465 GLY B 97 REMARK 465 VAL B 108 REMARK 465 ALA B 109 REMARK 465 ALA B 110 REMARK 465 PRO B 111 REMARK 465 SER B 112 REMARK 465 VAL B 113 REMARK 465 PHE B 114 REMARK 465 ILE B 115 REMARK 465 PHE B 116 REMARK 465 PRO B 117 REMARK 465 PRO B 118 REMARK 465 SER B 119 REMARK 465 ASP B 120 REMARK 465 GLU B 121 REMARK 465 GLN B 122 REMARK 465 LEU B 123 REMARK 465 LYS B 124 REMARK 465 SER B 125 REMARK 465 GLY B 126 REMARK 465 THR B 127 REMARK 465 ALA B 128 REMARK 465 SER B 129 REMARK 465 VAL B 130 REMARK 465 VAL B 131 REMARK 465 CYS B 132 REMARK 465 LEU B 133 REMARK 465 LEU B 134 REMARK 465 ASN B 135 REMARK 465 LYS B 143 REMARK 465 VAL B 144 REMARK 465 GLN B 145 REMARK 465 GLU B 159 REMARK 465 SER B 160 REMARK 465 SER B 180 REMARK 465 LYS B 181 REMARK 465 LYS B 186 REMARK 465 TYR B 190 REMARK 465 GLU B 193 REMARK 465 VAL B 194 REMARK 465 PRO B 202 REMARK 465 VAL B 203 REMARK 465 THR B 204 REMARK 465 LYS B 205 REMARK 465 SER B 206 REMARK 465 PHE B 207 REMARK 465 ASN B 208 REMARK 465 ARG B 209 REMARK 465 GLY B 210 REMARK 465 GLU B 211 REMARK 465 CYS B 212 REMARK 465 ASN C 252 REMARK 465 LEU C 253 REMARK 465 GLU C 254 REMARK 465 PRO C 331 REMARK 465 SER C 332 REMARK 465 SER C 333 REMARK 465 THR C 334 REMARK 465 GLU C 335 REMARK 465 PRO C 336 REMARK 465 SER C 337 REMARK 465 HIS C 338 REMARK 465 ALA C 339 REMARK 465 ARG C 340 REMARK 465 LEU C 341 REMARK 465 PRO C 342 REMARK 465 THR C 343 REMARK 465 ALA C 344 REMARK 465 GLY C 518 REMARK 465 SER C 519 REMARK 465 LEU C 520 REMARK 465 GLU C 521 REMARK 465 VAL C 522 REMARK 465 LEU C 523 REMARK 465 PHE C 524 REMARK 465 GLN C 525 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O SER B 91 NH2 ARG C 293 2.12 REMARK 500 OH TYR A 27 N TYR A 32 2.15 REMARK 500 O SER A 113 OG1 THR A 116 2.15 REMARK 500 OD2 ASP C 283 OH TYR C 362 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD1 ASP C 301 NZ LYS C 498 3444 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 48 -69.86 -99.61 REMARK 500 ASP A 57 -134.26 -94.56 REMARK 500 ARG A 59 76.67 -119.68 REMARK 500 SER A 63 -39.05 67.84 REMARK 500 TYR A 109 -118.99 -73.48 REMARK 500 SER A 113 -141.62 -147.13 REMARK 500 SER A 205 50.25 -92.01 REMARK 500 THR A 208 -66.85 -129.49 REMARK 500 TYR A 211 122.78 171.39 REMARK 500 CYS A 213 128.17 179.53 REMARK 500 MET B 4 -155.58 -139.13 REMARK 500 THR B 5 90.94 -62.63 REMARK 500 PRO B 8 -131.79 -121.25 REMARK 500 VAL B 19 -154.61 -127.44 REMARK 500 ARG B 24 -158.79 -128.14 REMARK 500 ASN B 30 -133.92 59.98 REMARK 500 TYR B 32 -77.05 -109.56 REMARK 500 LEU B 33 62.70 20.63 REMARK 500 LEU B 47 -69.45 -124.01 REMARK 500 SER B 52 -28.44 -162.61 REMARK 500 TYR B 87 -173.08 -178.04 REMARK 500 THR B 95 -131.74 59.06 REMARK 500 PHE B 104 118.65 -167.64 REMARK 500 ARG B 106 -154.56 82.15 REMARK 500 PRO B 139 -142.43 -78.44 REMARK 500 ASN B 150 73.87 -106.17 REMARK 500 ALA B 151 -154.38 58.70 REMARK 500 SER B 157 -135.39 59.08 REMARK 500 LYS B 188 -39.98 -146.88 REMARK 500 GLU C 256 107.88 -59.50 REMARK 500 CYS C 299 56.51 -116.24 REMARK 500 LEU C 323 34.72 70.46 REMARK 500 LYS C 326 74.68 -102.10 REMARK 500 THR C 327 -110.83 49.23 REMARK 500 LEU C 328 -66.69 -127.35 REMARK 500 PRO C 346 -122.73 -86.44 REMARK 500 SER C 371 -140.39 -149.32 REMARK 500 GLN C 383 -162.63 -120.60 REMARK 500 ARG C 387 -140.08 36.64 REMARK 500 ALA C 389 -79.24 -44.60 REMARK 500 GLU C 390 92.47 -174.04 REMARK 500 PRO C 392 78.63 -64.90 REMARK 500 THR C 396 50.30 -119.67 REMARK 500 ILE C 402 -57.97 -141.54 REMARK 500 ASN C 403 8.69 59.07 REMARK 500 LYS C 476 -70.11 -61.24 REMARK 500 ARG C 497 -95.55 -122.83 REMARK 500 ARG C 504 69.43 -168.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TYR B 86 TYR B 87 146.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8DCY RELATED DB: PDB REMARK 900 13G8FAB BOUND WITH GP38HOTI REMARK 900 RELATED ID: 8DC5 RELATED DB: PDB REMARK 900 FREE GP38 HOTI DBREF 8DDK A 1 243 PDB 8DDK 8DDK 1 243 DBREF 8DDK B 1 212 PDB 8DDK 8DDK 1 212 DBREF1 8DDK C 252 519 UNP A0A7T6Y557_9VIRU DBREF2 8DDK C A0A7T6Y557 252 519 SEQADV 8DDK LEU C 520 UNP A0A7T6Y55 EXPRESSION TAG SEQADV 8DDK GLU C 521 UNP A0A7T6Y55 EXPRESSION TAG SEQADV 8DDK VAL C 522 UNP A0A7T6Y55 EXPRESSION TAG SEQADV 8DDK LEU C 523 UNP A0A7T6Y55 EXPRESSION TAG SEQADV 8DDK PHE C 524 UNP A0A7T6Y55 EXPRESSION TAG SEQADV 8DDK GLN C 525 UNP A0A7T6Y55 EXPRESSION TAG SEQRES 1 A 243 GLU VAL GLN LEU VAL GLN SER GLY ALA GLU VAL LYS LYS SEQRES 2 A 243 PRO GLY GLU SER LEU ARG ILE SER CYS LYS GLY SER GLY SEQRES 3 A 243 TYR SER PHE THR SER TYR TRP ILE GLY TRP VAL ARG GLN SEQRES 4 A 243 MET PRO GLY LYS GLY LEU GLU TRP MET GLY ILE ILE TYR SEQRES 5 A 243 PRO GLY ASP SER ASP THR ARG TYR SER PRO SER PHE GLN SEQRES 6 A 243 GLY GLN VAL THR ILE SER ALA ASP LYS SER ILE SER THR SEQRES 7 A 243 ALA TYR LEU GLN TRP THR SER LEU LYS ALA SER ASP THR SEQRES 8 A 243 ALA MET TYR TYR CYS ALA ARG GLN LEU GLY GLY SER SER SEQRES 9 A 243 PHE GLY ASN TYR TYR ASP SER GLY SER TYR TYR THR ALA SEQRES 10 A 243 ALA TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER SER SEQRES 11 A 243 ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA PRO SEQRES 12 A 243 SER SER LYS SER THR SER GLY GLY THR ALA ALA LEU GLY SEQRES 13 A 243 CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR VAL SEQRES 14 A 243 SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS THR SEQRES 15 A 243 PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER LEU SEQRES 16 A 243 SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY THR SEQRES 17 A 243 GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER ASN SEQRES 18 A 243 THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SER CYS GLY SEQRES 19 A 243 SER HIS HIS HIS HIS HIS HIS HIS HIS SEQRES 1 B 212 ASP ILE GLN MET THR GLN SER PRO SER SER LEU SER ALA SEQRES 2 B 212 SER VAL GLY ASP ARG VAL THR ILE THR CYS ARG ALA SER SEQRES 3 B 212 GLN SER ILE ASN ASN TYR LEU ASN TRP TYR GLN GLN LYS SEQRES 4 B 212 PRO GLY LYS ALA PRO LYS LEU LEU ILE TYR ALA ALA SER SEQRES 5 B 212 THR LEU GLN SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 B 212 GLY SER GLY THR ASP PHE THR LEU THR ILE SER SER LEU SEQRES 7 B 212 GLN PRO GLU ASP PHE ALA SER TYR TYR CYS GLN GLN SER SEQRES 8 B 212 TYR ARG GLY THR PHE GLY GLN GLY THR LYS VAL GLU PHE SEQRES 9 B 212 LYS ARG THR VAL ALA ALA PRO SER VAL PHE ILE PHE PRO SEQRES 10 B 212 PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SER VAL SEQRES 11 B 212 VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU ALA LYS SEQRES 12 B 212 VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER GLY ASN SEQRES 13 B 212 SER GLN GLU SER VAL THR GLU GLN ASP SER LYS ASP SER SEQRES 14 B 212 THR TYR SER LEU SER SER THR LEU THR LEU SER LYS ALA SEQRES 15 B 212 ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU VAL THR SEQRES 16 B 212 HIS GLN GLY LEU SER SER PRO VAL THR LYS SER PHE ASN SEQRES 17 B 212 ARG GLY GLU CYS SEQRES 1 C 274 ASN LEU GLU MET GLU ILE ILE LEU THR LEU SER GLN GLY SEQRES 2 C 274 LEU LYS LYS TYR TYR GLY LYS ILE LEU LYS LEU LEU HIS SEQRES 3 C 274 LEU THR LEU GLU GLU ASP THR GLU GLY LEU LEU GLU TRP SEQRES 4 C 274 CYS LYS ARG ASN LEU GLY SER ASN CYS ASP ASP ASP PHE SEQRES 5 C 274 PHE GLN LYS ARG ILE GLU GLU PHE PHE ILE THR GLY GLU SEQRES 6 C 274 GLY TYR PHE ASN GLU VAL LEU GLN PHE LYS THR LEU SER SEQRES 7 C 274 THR PRO SER SER THR GLU PRO SER HIS ALA ARG LEU PRO SEQRES 8 C 274 THR ALA GLU PRO PHE LYS SER TYR PHE ALA LYS GLY PHE SEQRES 9 C 274 LEU SER ILE ASP SER GLY TYR PHE SER ALA LYS CYS TYR SEQRES 10 C 274 PRO ARG SER SER THR SER GLY LEU GLN LEU ILE ASN VAL SEQRES 11 C 274 THR GLN HIS PRO ALA ARG ILE ALA GLU THR PRO GLY PRO SEQRES 12 C 274 LYS THR THR SER LEU LYS THR ILE ASN CYS ILE ASN LEU SEQRES 13 C 274 ARG ALA SER VAL PHE LYS GLU HIS ARG GLU VAL GLU ILE SEQRES 14 C 274 ASN VAL LEU LEU PRO GLN ILE ALA VAL ASN LEU SER ASN SEQRES 15 C 274 CYS HIS VAL VAL ILE ASN SER HIS VAL CYS ASP TYR SER SEQRES 16 C 274 LEU ASP THR ASP GLY PRO VAL ARG LEU PRO ARG ILE TYR SEQRES 17 C 274 HIS GLU GLY THR PHE MET PRO GLY THR TYR LYS ILE VAL SEQRES 18 C 274 ILE ASP ARG LYS ASN LYS LEU ASN ASP ARG CYS THR LEU SEQRES 19 C 274 VAL THR ASN CYS VAL ILE LYS GLY ARG GLU VAL ARG LYS SEQRES 20 C 274 GLY GLN SER VAL LEU ARG GLN TYR LYS THR GLU ILE LYS SEQRES 21 C 274 ILE GLY LYS ALA PRO THR GLY SER LEU GLU VAL LEU PHE SEQRES 22 C 274 GLN HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET MAN D 4 11 HET MAN D 5 11 HET MAN D 6 11 HET NAG E 1 14 HET NAG E 2 14 HET BMA E 3 11 HET MAN E 4 11 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 4 NAG 4(C8 H15 N O6) FORMUL 4 BMA 2(C6 H12 O6) FORMUL 4 MAN 4(C6 H12 O6) FORMUL 6 HOH *(H2 O) HELIX 1 AA1 LYS A 87 THR A 91 5 5 HELIX 2 AA2 THR C 260 LEU C 276 1 17 HELIX 3 AA3 GLY C 286 LEU C 295 1 10 HELIX 4 AA4 ASP C 300 ILE C 313 1 14 HELIX 5 AA5 PRO C 346 TYR C 350 5 5 HELIX 6 AA6 THR C 373 LEU C 378 1 6 HELIX 7 AA7 ASN C 477 ASP C 481 5 5 SHEET 1 AA1 4 GLN A 3 GLN A 6 0 SHEET 2 AA1 4 LEU A 18 SER A 25 -1 O LYS A 23 N VAL A 5 SHEET 3 AA1 4 THR A 78 TRP A 83 -1 O LEU A 81 N ILE A 20 SHEET 4 AA1 4 THR A 69 ASP A 73 -1 N SER A 71 O TYR A 80 SHEET 1 AA2 6 GLU A 10 LYS A 12 0 SHEET 2 AA2 6 THR A 124 VAL A 128 1 O THR A 127 N GLU A 10 SHEET 3 AA2 6 ALA A 92 ARG A 98 -1 N ALA A 92 O VAL A 126 SHEET 4 AA2 6 ILE A 34 GLN A 39 -1 N GLN A 39 O MET A 93 SHEET 5 AA2 6 GLU A 46 ILE A 51 -1 O GLU A 46 N ARG A 38 SHEET 6 AA2 6 ARG A 59 TYR A 60 -1 O ARG A 59 N ILE A 50 SHEET 1 AA3 3 THR A 168 SER A 170 0 SHEET 2 AA3 3 ASN A 214 HIS A 217 -1 O ASN A 214 N SER A 170 SHEET 3 AA3 3 THR A 222 ASP A 225 -1 O VAL A 224 N VAL A 215 SHEET 1 AA4 2 VAL A 186 LEU A 187 0 SHEET 2 AA4 2 TYR A 193 SER A 194 -1 O SER A 194 N VAL A 186 SHEET 1 AA5 3 THR B 20 ARG B 24 0 SHEET 2 AA5 3 ASP B 70 THR B 74 -1 O LEU B 73 N ILE B 21 SHEET 3 AA5 3 SER B 63 SER B 67 -1 N SER B 65 O THR B 72 SHEET 1 AA6 2 ILE B 48 TYR B 49 0 SHEET 2 AA6 2 THR B 53 LEU B 54 -1 O THR B 53 N TYR B 49 SHEET 1 AA7 2 SER B 85 TYR B 86 0 SHEET 2 AA7 2 THR B 100 LYS B 101 -1 O THR B 100 N TYR B 86 SHEET 1 AA8 7 LEU C 356 ASP C 359 0 SHEET 2 AA8 7 SER C 364 CYS C 367 -1 O CYS C 367 N LEU C 356 SHEET 3 AA8 7 CYS C 443 LEU C 447 -1 O ASP C 444 N LYS C 366 SHEET 4 AA8 7 VAL C 436 SER C 440 -1 N ILE C 438 O TYR C 445 SHEET 5 AA8 7 TYR C 469 ASP C 474 -1 O VAL C 472 N VAL C 437 SHEET 6 AA8 7 GLU C 417 VAL C 422 -1 N ILE C 420 O ILE C 471 SHEET 7 AA8 7 LEU C 407 PHE C 412 -1 N ARG C 408 O ASN C 421 SHEET 1 AA9 3 VAL C 429 SER C 432 0 SHEET 2 AA9 3 THR C 484 CYS C 489 -1 O THR C 484 N SER C 432 SHEET 3 AA9 3 TYR C 506 LYS C 511 -1 O ILE C 510 N LEU C 485 SHEET 1 AB1 2 ILE C 458 TYR C 459 0 SHEET 2 AB1 2 THR C 463 PHE C 464 -1 O PHE C 464 N ILE C 458 SSBOND 1 CYS A 22 CYS A 96 1555 1555 2.03 SSBOND 2 CYS C 291 CYS C 299 1555 1555 2.04 SSBOND 3 CYS C 367 CYS C 443 1555 1555 2.03 SSBOND 4 CYS C 404 CYS C 489 1555 1555 2.03 SSBOND 5 CYS C 434 CYS C 483 1555 1555 2.03 LINK ND2 ASN C 380 C1 NAG E 1 1555 1555 1.44 LINK ND2 ASN C 430 C1 NAG D 1 1555 1555 1.44 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.44 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.43 LINK O3 NAG D 2 C1 MAN D 6 1555 1555 1.50 LINK O3 BMA D 3 C1 MAN D 4 1555 1555 1.48 LINK O2 MAN D 4 C1 MAN D 5 1555 1555 1.47 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.46 LINK O4 NAG E 2 C1 BMA E 3 1555 1555 1.45 LINK O3 BMA E 3 C1 MAN E 4 1555 1555 1.45 CISPEP 1 PHE A 163 PRO A 164 0 -6.06 CISPEP 2 GLU A 165 PRO A 166 0 -3.66 CISPEP 3 TYR B 138 PRO B 139 0 4.47 CRYST1 175.676 175.676 92.158 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005692 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005692 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010851 0.00000